HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ichiro Hisatome Selected Research

Hyperuricemia

6/2022C-reactive Protein Levels and Cardiovascular Outcomes After Febuxostat Treatment in Patients with Asymptomatic Hyperuricemia: Post-hoc Analysis of a Randomized Controlled Study.
2/2022Effect of febuxostat on clinical outcomes in patients with hyperuricemia and cardiovascular disease.
1/2022Lactobacillus gasseri PA-3 reduces serum uric acid levels in patients with marginal hyperuricemia.
1/2021Uric Acid as a Risk Factor for Chronic Kidney Disease and Cardiovascular Disease - Japanese Guideline on the Management of Asymptomatic Hyperuricemia.
1/2021Comparative effects of topiroxostat and febuxostat on arterial properties in hypertensive patients with hyperuricemia.
7/2020Evidence for Urate Uptake Through Monocarboxylate Transporter 9 Expressed in Mammalian Cells and Its Enhancement by Heat Shock.
1/2020Recent approaches to gout drug discovery: an update.
11/2019Hyperuricemia as a Risk Factor for Atrial Fibrillation Due to Soluble and Crystalized Uric Acid.
1/2019High rate of calories from protein is associated with higher prevalence of hypertension.
1/2018Uric Acid Is a Strong Risk Marker for Developing Hypertension From Prehypertension: A 5-Year Japanese Cohort Study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ichiro Hisatome Research Topics

Disease

27Hyperuricemia
06/2022 - 01/2003
22Heart Failure
01/2022 - 03/2002
20Hypertension (High Blood Pressure)
01/2021 - 09/2002
11Cardiovascular Diseases (Cardiovascular Disease)
02/2022 - 09/2003
11Insulin Resistance
01/2021 - 03/2007
10Ischemia
01/2018 - 09/2003
8Chronic Renal Insufficiency
01/2021 - 12/2014
7Gout
02/2022 - 01/2010
7Myocardial Infarction
01/2022 - 08/2005
7Hypoxia (Hypoxemia)
01/2022 - 06/2004
7Dyslipidemias (Dyslipidemia)
03/2020 - 08/2014
6Inflammation (Inflammations)
06/2022 - 07/2009
6Atrial Fibrillation
11/2019 - 08/2009
5Diabetes Mellitus
01/2019 - 09/2002
4Non-alcoholic Fatty Liver Disease
01/2021 - 06/2010
4Reperfusion Injury
01/2020 - 09/2003
4Obesity
11/2017 - 06/2008
3Thrombosis (Thrombus)
11/2020 - 11/2004
3Renal hypouricemia
04/2019 - 01/2004
3Left Ventricular Dysfunction
01/2018 - 09/2003
3Long QT Syndrome
10/2016 - 02/2011
3Disease Progression
05/2011 - 11/2004
2Cardiac Arrhythmias (Arrythmia)
10/2022 - 11/2011
2Juvenile gout
06/2022 - 08/2015
2Type 2 Diabetes Mellitus (MODY)
01/2022 - 01/2019
2Hepatocellular Carcinoma (Hepatoma)
01/2021 - 05/2011
2Bradycardia
11/2019 - 01/2019
2Hepatitis
10/2018 - 03/2006
2Colitis
10/2018 - 04/2005
2Dehydration (Water Stress)
01/2017 - 04/2008
2Long Qt Syndrome 2
11/2016 - 12/2013
2Hyperglycemia
01/2014 - 04/2008
2Lung Injury
04/2013 - 04/2007
2Hemorrhage
04/2013 - 08/2005
2Hypertrophic Cardiomyopathy (Hypertrophic Obstructive Cardiomyopathy)
11/2011 - 12/2008
2Thyroiditis
11/2009 - 02/2009
2Thyroid Diseases (Thyroid Disease)
02/2009 - 08/2004
2Graves Disease (Basedow Disease)
02/2009 - 08/2004

Drug/Important Bio-Agent (IBA)

45Uric Acid (Urate)IBA
07/2022 - 01/2004
10Proteins (Proteins, Gene)FDA Link
06/2022 - 07/2002
7Xanthine OxidaseIBA
01/2017 - 09/2003
6FebuxostatFDA Link
06/2022 - 01/2017
6Messenger RNA (mRNA)IBA
01/2022 - 04/2007
6Reactive Oxygen Species (Oxygen Radicals)IBA
01/2021 - 06/2010
6Insulin (Novolin)FDA Link
01/2021 - 01/2010
6purineIBA
08/2015 - 09/2003
5Glucose (Dextrose)FDA LinkGeneric
01/2017 - 08/2013
4Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2022 - 01/2014
4FYX-051IBA
01/2021 - 12/2014
4Blood Glucose (Blood Sugar)IBA
05/2020 - 11/2017
4SodiumIBA
05/2020 - 12/2009
4SaltsIBA
05/2020 - 04/2008
4Antihypertensive Agents (Antihypertensives)IBA
08/2014 - 09/2002
4CytokinesIBA
02/2014 - 01/2003
3InflammasomesIBA
07/2022 - 11/2019
3C-Reactive ProteinIBA
06/2022 - 08/2002
3Norepinephrine (Noradrenaline)FDA LinkGeneric
01/2022 - 03/2002
3HypoxanthineIBA
01/2022 - 09/2003
3Uricosuric AgentsIBA
01/2020 - 01/2010
3Pharmaceutical PreparationsIBA
01/2020 - 01/2003
3AntioxidantsIBA
11/2019 - 07/2016
3ORALIT (ORS)IBA
01/2019 - 08/2014
3Proteasome Endopeptidase Complex (Proteasome)IBA
09/2015 - 03/2003
3Losartan (Cozaar)FDA LinkGeneric
01/2014 - 02/2004
3Inosine Monophosphate (IMP)IBA
04/2013 - 09/2003
3Adenosine Monophosphate (AMP)IBA
04/2013 - 09/2003
3RetinoidsIBA
05/2011 - 06/2010
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
11/2010 - 12/2002
3Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2010 - 01/2003
2UromodulinIBA
06/2022 - 08/2015
2XanthineIBA
01/2022 - 09/2003
2EnzymesIBA
01/2020 - 03/2006
2cilnidipineIBA
01/2020 - 01/2012
2Adrenergic Agents (Adrenergic Drugs)IBA
01/2019 - 01/2015
2Angiotensin IIIBA
12/2018 - 11/2010
2IrbesartanFDA LinkGeneric
12/2018 - 01/2014
2Biological ProductsIBA
11/2018 - 12/2005
2Cyclooxygenase 2 (Cyclooxygenase-2)IBA
09/2016 - 02/2010
2potassium oxonateIBA
01/2016 - 05/2014
2UbiquitinIBA
09/2015 - 12/2008
2AlbuminsIBA
12/2014 - 12/2009
2DiureticsIBA
02/2014 - 06/2007
2Furosemide (Lasix)FDA LinkGeneric
02/2014 - 11/2004
2AMP Deaminase (Myoadenylate Deaminase)IBA
04/2013 - 04/2007
2Carrier Proteins (Binding Protein)IBA
11/2011 - 12/2008
2Cardiac MyosinsIBA
11/2011 - 12/2008
2NG-Nitroarginine Methyl Ester (L-NAME)IBA
05/2011 - 11/2009
2ThioredoxinsIBA
05/2011 - 03/2006
2CatalaseIBA
12/2010 - 03/2006
2BenzbromaroneIBA
01/2010 - 01/2004
2Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA
10/2009 - 04/2005
2sodium-iodide symporter (sodium iodide symporter)IBA
02/2009 - 07/2002
2AutoantigensIBA
02/2009 - 08/2004
2AntibodiesIBA
02/2009 - 08/2004
2Adenosine (Adenocard)FDA LinkGeneric
09/2007 - 12/2006
2Allopurinol (Remid)FDA LinkGeneric
11/2006 - 09/2003

Therapy/Procedure

12Therapeutics
01/2022 - 09/2003
3Transplantation
12/2018 - 02/2013
2Catheter Ablation
08/2009 - 07/2004
2Ligation
04/2007 - 11/2006